Tuesday, September 26, 2023

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Sleep Crisis Affects Mental Health of Students in U.S.

sleepy student

At least 50 percent of middle school students and 75 percent of high school students in the United States are not getting enough hours of sleep on a daily basis, according to the U.S. Centers for Disease Control and Prevention (CDC).1 Commenting on children not getting enough sleep, Oleg Tarkovsky, director of Behavioral Health Services […]

COVID Shot Transmits Aerosolized Antibodies to Those Who’ve Not Gotten It: Study

people facing each other

A peer reviewed study recently published in Immunohorizons has provided evidence that individuals, who received messenger RNA (mRNA) COVID-19 shots, are able to transmit aerosolized antibodies to unvaccinated individuals. The study, which was originally reported in preprint in May 2022, looked at masks worn for one day by laboratory workers who received a COVID shot. […]

First Over-the-Counter Birth Control Pill Approved by FDA

birth control pill

On July 13, 2023, the U.S. Food and Drug Administration (FDA) approved the first ever non-prescription birth control pill. The progestin-only oral contraceptive known as Opill (norgestrel) is expected to be available in pharmacies, supermarkets, and convenience stores by early 2024. Opill claims a 93 percent efficacy rate in pregnancy prevention.1 Norgestrel Originally Approved in […]

More Evidence SARS CoV-2 Escaped from Chinese Laboratory

Wuhan Laboratory

U.S. government officials have admitted that the first patients infected with the SARS-CoV-2 virus were researchers working at the Wuhan Institute of Virology (WIV) in China, despite claims by former director of the U.S. National Institute of Allergy and Infectious Disease (NIAID) Anthony Fauci, MD that “we may never know” the true origin of the […]

FDA Panel Endorses New Alzheimer’s Drug After Accelerated Approval

elderly man

The newest Alzheimer’s drug is on its way for full regulatory approval after a U.S. Food and Drug Administration (FDA) advisory panel voted that the drug was beneficial in slowing cognitive decline. The drug is expected to be fully approved by July 6, 2023.1 In clinical trials the drug, known as lecanemab, demonstrated a 27 […]

Search in Site

To search in site, type your keyword and hit enter